In turn, western blot analysis showed that miR-636 negatively regulated the expression of KLF9 (Figure 5G), while in vitro assays indicated that KLF9 silencing promoted the proliferation of BC cell lines (Figure 5H, 5I). Here, KLF9 is linked to breast cancer.